Biodegradable polymers, either as porous scaffolds or microspheres, have been investigated broadly for cartilage tissue engineering. A combination of these two forms of materials could potentially maximize their benefits. In this study, porous poly (L-lactide-co-ε-caprolactone) (PLCL) scaffolds were integrated with poly (β-hydroxybutyrate-co-β-hydroxyvalerate) (PHBV) microspheres to enhance the mechanical properties of the scaffolds as well as to potentially regulate cell behavior through altering surface topography. PHBV microspheres fabricated with an emulsion solvent evaporation method were incorporated into PLCL scaffolds (0%, 20%, 40% and 50% W/W). Compressive modulus, surface topography and porosity of the composite scaffolds were evaluated, and in vitro and in vivo chondrogenesis within the chondrocyte-laden scaffolds was investigated by examining proliferation of chondrocytes and the deposition of glycosaminoglycan (GAG) and type II collagen. The results showed significant enhancement of the compressive modulus of the scaffolds incorporated with PHBV microspheres, while Young's modulus of the scaffolds with 50% PHBV incorporation was 3.3 times higher than PLCL scaffolds alone. The porosity of the composite scaffolds was kept constant for all levels of PHBV incorporation. Though the PLCL scaffolds incorporated with microspheres showed no significant effects on adhesion at 6 h as well as in vitro cartilage formation and proliferation of the chondrocytes at both 2 weeks and 4 weeks, total contents of GAG and type II collagen excreted increased significantly with time. The chondrocyte-laden scaffolds formed cartilage-like tissues at 4 and 8 weeks after implantation in nude mice, with increased staining density of type II collagen and GAG over time. In conclusion, incorporation of PHBV microspheres not only enhanced the compressive
Introduction
Once damaged, articular cartilage has a poor ability to regenerate, mainly due to lack of blood and nerve supply, constrained cell motion, limited ability of existing chondrocytes to proliferate, and a complex physiological and mechanical environment [1] . Cartilage tissue engineering is one of the most effective strategies to regenerate cartilage defects and has been widely investigated and adopted clinically; however, there are still many challenges such as in vitro chondrocyte dedifferentiation, poor integration with host cartilage and lack of scaffolds with mechanical properties compatible with cartilage [2] . Scaffolds used for cartilage tissue engineering should not only withstand mechanical stimulus to maintain structural integrity, but also transfer mechanical signals to individual chondrocytes to regulate their functionality. At best, scaffolds could support and regulate the organization and subsequent proliferation of seeded cells through controlled release of biochemical factors and different physical/chemical properties [3] .
Mechanical properties of biomaterials are of great importance for cartilage regeneration, especially the aggregate compressive Young's modulus and viscoelasticity. To avoid deterioration under repetitive physiological loads, biomaterials should have a compressive Young's modulus comparable to native cartilage, which varies between 0.4 and 0.8 MPa [4] . Proteoglycans and collagen, as well as their interaction, provide articular cartilage with the unique physical properties to withstand mechanical stress [1] . An anisotropic 3D woven poly-glycolic acid structure has been fabricated with mechanical properties similar to native cartilage [5] . However, further study of this structure has yet to be reported in cartilage tissue engineering, which could partially be attributed to incompliance of its unnatural structures with natural cartilage. In order to attain the required strength, multiple scaffolds made of different materials (chitosan, collagen, Poly (lacticco-glycolic acid), Poly (lactic acid), Poly (β-hydroxybutyrateco-β-hydroxyvalerate) and different structures (sponges, hydrogels and woven structures) have been developed [6] [7] [8] [9] . However, additional strategies to chemically crosslink the material are required to maintain sustainable strength or for optimization of internal structures.
Viscoelastic properties of biomaterial scaffolds similar to natural cartilage are also critical for scaffolds to maintain their structures under repetitive physiological loads as well as to transfer proper mechanical signals to chondrocytes within the scaffolds. Cyclic mechanical stimuli could regulate the phenotype of chondrocytes [10] , while proper viscoelastic properties of the biomaterials could facilitate transmission of the mechanical stimuli to both cartilage and chondrocytes.
Three kinds of biodegradable elastomers including poly (1, 8-octanediol citrate) (POC), poly (glycerol-sebacate) (PGS) and poly-ε-caprolactone (PCL) have been shown to enhance the quality of engineered cartilage under dynamic compression in vitro [8, 11] . Both POC and PGS have a three-dimensional crosslinked network of random coils analogous to vulcanized rubber, while PCL is made of linear molecular chains without crosslinks. Their chemical properties, such as hydrophilicity as well as rate and pattern of degradation, can be tailored by grafting hydrophobic moieties to the hydroxyl groups. However, the aforementioned elastomers have a notably low Young's modulus and high yield strain, which are incompatible for cartilage regeneration. Poly (L-lactide-co-ε-caprolactone, PLCL), made of poly lactic acid (PLA) and PCL, with a molar ratio of 7:3 is a highly elastic and linear biodegradable polymer with a relatively mild degradation, which avoids an abrupt drop in pH value during degradation, similar to PLA and PGA scaffolds [12, 13] . However, the relatively low compressive modulus should be enhanced when used in cartilage regeneration. Three methods could be used to improve the strength of the scaffold materials: choosing materials which are of great strength, improving strength with chemical crosslinking and incorporating stiffer materials within the elastic scaffolds. Until recently, methods to further improve the compressive strength of pure PLCL scaffolds were inadequate due to the fact that PLCL is a linear elastomer which lacks the capability of being enhanced through crosslinking [2, 3] .
Integration of materials with a high Young's modulus is a promising strategy for improving the mechanical properties of viscoelastic scaffolds. Elastic PLCL was blended with stiff PLGA to improve the compressive Young's modulus to 12.9 MPa, which could maintain its architecture during the in vitro experiment [14] . Biocompatible poly (β-hydroxybutyrate-co-β-hydroxyvalerate) (PHBV) with a relatively high elastic modulus (1.2 GPa) is a promising candidate for improving the mechanical properties of scaffolds [15] . PHBV copolymers with 8% hydroxyvalerate (HV) have been used for cartilage regeneration, which facilitated chondrogenic differentiation in vitro and in vivo [16] . PHBV could not only help to maintain chondrogenic phenotype of pre-differentiated human adipose-derived stem cells, but cell/PHBV constructs could also produce neo-cartilage in a heterotopic site [17] . Furthermore, incorporation of PHBV microspheres may regulate the functionality of chondrocytes through altering the surface topography and provide the potential to include bioactive factors [18] .
Porous PLCL scaffolds have previously been fabricated for cartilage tissue engineering; however, their low compressive Young's modulus hindered their utility [3, 19, 20] . In this study, PHBV microspheres were integrated into the PLCL scaffolds with an aim to improve the Young's modulus and increase surface topography for the attachment of chondrocytes. The composite scaffolds were fabricated with a combination of porogen-leaching and lyophilization methods. Morphology, compressive modulus and porosity of the composite scaffolds were characterized. Proliferation and differentiation of the chondrocytes on the scaffolds were evaluated in vitro, while extracellular matrix (ECM) deposition was investigated in vitro and in vivo.
Experimental section

Preparation of PHBV microspheres
PHBV microspheres were fabricated using an emulsion solvent evaporation technique [21] . A 2% PHBV solution was made by dissolving 0.5 g of PHBV (8% hydroxyvalerate (HV) content, Goodfellow Cambridge Limited, UK) in 25 mL of methylene chloride. The solution was then quickly poured into 500 mL of deionized water containing 0.5% (W/V) polyvinyl alcohol (PVA124, Guoyao Chemical Reagents Limited, Beijing, China) under agitation at a speed of 1000 rpm for 12 h, until the organic solvent was completely evaporated. The microspheres were collected after centrifugation at 4000 rpm for 3 min, washed three times with deionized water to remove PVA, and then freeze-dried for 24 h.
PHBV microsphere size analysis
Size distribution of the PHBV microspheres was determined using a light-scattering particle size analyzer (Matersizer 2000, Malvern Instrument Ltd, UK). The desiccated microspheres were suspended in 1000 mL of distilled water and analyzed after continuous stirring.
Integration of PHBV microspheres with PLCL scaffolds
Three-dimensional PLCL scaffolds were fabricated with a porogen-leaching method, as described previously [22] . 0.5 g of PLCL (7:3; Mw 23 000 Da, Daigang Biomaterials Inc. Jinan, China) was dissolved in acetone. Following fabrication of PLCL scaffolds, 0, 0.1, 0.2 or 0.25 g PHBV microspheres with 8.0 g sodium chloride (200-300 μm) were suspended in the PLCL solution to fabricate PLCL, 20% PHBV/PLCL, 40% PHBV/PLCL and 50% PHBV/PLCL scaffolds, respectively. After agitation, the composite mixtures were cast in glass molds before exposure to air for 48 h to fully evaporate the solvent. The mixtures were then rinsed to remove NaCl crystals. Composite scaffolds were frozen at −20
• C before being lyophilized for 24 h. After lyophilization, the acquired scaffolds were stored in a desiccator until usage (figure 1).
Scanning electron microscopy
The scaffolds were sectioned using a scalpel, before being fixed and sputter coated with gold for 80 s at 18 mA. Internal structures of the scaffolds and PHBV microspheres were observed by scanning electron microscopy (SEM; Quanta 200FEG, FEI, USA) at an accelerating voltage of 5 kV.
Porosity of the scaffolds
Porosity of the scaffolds was estimated using a previous methodology [23] . Sizes of the scaffolds were measured with a vernier caliper, and the weight of the scaffolds was recorded. The scaffolds were then immersed in absolute alcohol for 2 h and weight was assessed once more. Porosity was calculated as (Ws-Wd)/ρ/V, where ρ represented the density of alcohol and V represented volume of the scaffolds, respectively.
Compression test
An unconfined compression test was carried out with an Instron 5843 mechanical testing system (Instron Corporation, America). Compressive loads were applied to individual specimens in a PBS bath using a stainless steel indenter. All samples were pre-loaded three times to a 10% strain before a constant loading was applied at a displacement of 0.5 mm min −1 until 45% of strain was reached. The measured thickness was converted to the strain of the sample (ε = 1 − L/L 0 , where L 0 and L represent the thickness before and after compression, respectively). Young's modulus (E = σ /ε, where σ and ε denote the stress and strain of the sample, respectively) was determined automatically. This process was repeated on four specimens for each sample type.
Isolation and culture of primary chondrocytes
Primary chondrocytes were isolated from articular cartilage of an adult pig (Yorkshire, 10-12 months). Cartilage slices collected from the femoral condyle were first digested with 0.25% TrypLE (Invitrogen) for 30 min and then with 0.25% (w/v) type II collagenase solution (17101-015, Gibco, USA) in Dulbecco's modified Eagle's medium (DMEM, 31600-034, Invitrogen, USA) with 1 g tissue/5 mL collagenase solution. The mixture was incubated for 12-16 h at 37
• C with intermittent agitation before the cells were collected through a strainer mesh (200 mesh, 74 μm, Solarbio, Fr) and counted with a hemocytometer. The chondrocytes were added at a density of 4000 cells cm −2 , cultured with DMEM, and supplemented with 10% fetal bovine serum (FBS, SV30087.02, Gibco) with 100 U mL −1 PS (Penicillin, 0741; Streptomycin, 0832, Amresco, USA). The cell cultures were incubated at 37
• C in a humidified environment with 5% CO 2 . Culture media was changed every 72 h, and cells were passaged when 80% confluence was reached. Passage 1 chondrocytes were used in the experiment.
Preparation of the scaffolds and cell seeding.
The scaffolds were cut into disks of length × width × height = 4 × 4 × 2 mm 3 and sterilized with 75% (V/V) ethanol solution for 2 h followed by 30 min of ultraviolet radiation. All scaffolds were pre-soaked with DMEM for 24 h before cell seeding. 30 μL of cell suspension (1 × 10 7 cells mL −1 ) were loaded drop-wise onto the top of the scaffolds and incubated at 37
• C for 60 min before 100 μL of culture medium was added to immerse the scaffolds. The immersed scaffolds were incubated at 37
• C in a humidified incubator of 5% CO 2 .
Attachment and proliferation of the chondrocytes.
Cell attachment (6 h) and cell proliferation (2 and 4 weeks) were evaluated with Hoechst 33258. The cells were digested with 1 mL of 3 mg mL −1 proteinase K (H10091, Merck, Germany) overnight at 57
• C at pre-scheduled time points. One hundred microliters of 0.1 mg mL −1 of H33258 was used to dye 100 μL digested solution in 96-well plates (Berthold). Fluorescence intensity was measured on a microplate reader (Synergy, BioTek, USA) at excitation and emission wavelengths of 360 and 465 nm, respectively. A calibration curve was obtained from DNA standard solutions with known concentrations of cells. Four replicates were used for each time point.
Live/dead characterization.
After the chondrocytes were cultured in the scaffolds (length × width × height = 4 × 4 × 2 mm 3 ) for prescheduled periods (6 h, 2 w), the scaffolds were sequentially incubated with 100 μL of 2 μL mL −1 fluorescein diacetate solution (FDA, F7378, Sigma) for 15 min and followed by 100 μL of 5 μg mL −1 of propidium iodide solution (PI, P4170, Sigma) for another 5 min at 37
• C. The constructs were evaluated with confocal laser scanning microscopy (CLSM, LSM510, Zeiss, Germany) at excitation wavelength of 488 nm and emission wavelengths of 550-670 nm. Morphology and spatial distribution of the cells were evaluated.
Glycosaminoglycan quantification.
Sulfated GAG concentration of chondrocytes/scaffolds constructs was determined with dimethylmethylene blue (DMMB, 341088, Sigma) after in vitro culture for 2 or 4 weeks [24] . The constructs were digested in 3 mg mL −1 proteinase K (H10091, Merck, Germany) overnight at 57
• C. 1.0 mL of working DMMB solution (16 μg mL −1 DMMB 2.5% ethanol, 1 M guanidine hydrochloride (GuHCl), 0.2 g L −1 sodium formate and 2% formic acid) was mixed with 100 μL of digestive solution, vortexed for 30 min and centrifuged at 9600g for 10 min. After discarding the supernatant, 1.0 mL of decomplexation solution (50 mM sodium acetate solution buffer (pH 6.8), 10% propan-1-ol, 4 M GuHCl) was added and incubated for 30 min. Absorbance was measured at 656 nm. The standard curve was determined as follows: 0.01 g chondroitin sulfate (CS) (Sigma; CAS: 39455-18-0) was dissolved into 10 mL ionized water, and the solution was diluted to 40/20/10/4/2 times to form 0.025/0.05/0.1/0.25/0.5 mg mL −1 CS solutions. In addition, 2/3/4/5 mg ml −1 CS solutions were also prepared. Absorbance was measured at 656 nm. Contents of sGAG were extrapolated from the standard curve. The process was completed three times.
Quantitative PCR.
The samples were lysed in 1.0 mL Trizol (15596-026, Invitrogen) for 10 min after in vitro culture for 2 or 4 weeks. The total RNA was extracted from the cell-scaffold constructs following the manufacturer's instructions. cDNA was reverse transcribed using iScript TM cDNA synthesis kit (Bio-Rad, Hercules, CA) following manufacturer's instructions. Real-time PCR was performed using the Power SYBR Green PCR Master Mix (Applied Biosystem, Foster City, CA) on Applied Biosystems 7500 Real-Time PCR System (Applied Biosystem) at 95
• C for 15 min followed by 40 cycles of 15 s denaturation at 94
• C, 30 s annealing at 55
• C and 30 s elongation at 72
• C. Each sample was repeated three times for each gene of interest. Genes of interest were normalized to the reference gene glyceraldehydes-3-phosphate dehydrogenase (GAPDH). Gene expression was calculated as 2 − Ct . The following forward and reverse primers were used for amplification [25] : for GAPDH, forward 5 -ATGGTGAAGGTCGGAGTGAA-3 ; reverse 5 -AATGAAGGGGTCATTGATGG-3 ; for aggrecan, forward 5 -CATCACCGAGGGTGAAGC-3 ; reverse 5 -CCAGGGGCAAATGTAAAGG-3 ; for type II collagen, forward 5 -TGAGAGGTCTTCCTGGCAAA-3 ; reverse 5 -GAAGTCCCTGGAAGCCAGAT-3 . The process was completed three times.
In vivo studies
The animal study was approved by the Institutional Animal Care and Usage Committee (IACUC) of Peking University. Six 7-week-old male athymic mice (SPF, Vital River, China) were used for this study. An intramuscular injection of 2.5 mg mL −1 of ketamine (50 mg kg
) was administered before three mid-sagittal skin incisions of 5 mm over the back of the mice were made. Each construct, with porcine cells cultured in vitro for 10 days, was inserted into subcutaneous cavities separately, and a total of six constructs were implanted in each mouse. Subcutaneous tissue and skin were sutured layer by layer before covering incisions with penicillin powder and gauze. Mice were killed at 4 or 8 weeks, and the implants were harvested. Two replicates were assessed.
Histological and immunohistological assessment.
The samples were fixed in 10% (v/v) buffered formalin, dehydrated and embedded for histological analysis. The specimens were sectioned into 5 μm thick sections and stained with hematoxylin and eosin (H&E). For alcian blue staining, the tissue sections were incubated with 0.5% alcian blue (SigmaAldrich) in 0.1M HCl for 30 min and counterstained with nuclear fast red (Sigma-Aldrich). For immunohistochemistry staining, tissue sections were incubated with hydrogen peroxide and pepsin for 20 min separately. The sections were incubated for an hour with a 1:500 dilution of monoclonal antibodies of type II collagen (Clone 6B3; Chemicon Inc., Temecuela, CA) and then incubated with biotinylated goat anti-mouse (Lab Vision Corporation, Fremont, CA) for 30 min. The sections were incubated with streptavidin, peroxidase and 3, 3 -diaminobenzidine before counterstaining with hematoxylin.
Statistical analysis
SPSS V 18.0 (SPSS Inc., IL, USA) was utilized to analyze the data, and a one-way analysis of variance (ANOVA) statistical test (P < 0.05, Tukey) was used to compare the difference between each group. All data were expressed as mean ± standard deviation.
Results
Characterization of PHBV microspheres
Fabricated PHBV microspheres had a relatively narrow particle size distribution with a median particle diameter of 37.2 μm (90% of the microspheres distributed from 22.7 to 61.4 μm) (figure 2). PHBV microspheres had spherical shapes and rough surfaces. Diameters of most of the PHBV microspheres were less than 50 μm, which was in accordance with the findings of the size distribution analysis (figure 3).
Characterization of different scaffolds
More microspheres were seen in the composite scaffolds with higher percentages of PHBV microsphere integration, though pore sizes of the composite scaffolds remained constant. The microspheres were uniformly distributed across and integrated within the PLCL matrix (figure 4). PHBV microspheres were prominent in the internal surface of the matrix which changed the surface topography of composite scaffolds on the micro scale. The porosities of the scaffolds remained relatively unchanged with integration of the PHBV microspheres, varying from 83.0 ± 3.6% (pure PLCL scaffold), 83.5 ± 7.1% (20% PHBV) to 88.5 ± 3.5% (40% PHBV) (P > 0.05). Even when the concentration of PHBV microspheres was 50% (84.9 ± 2.3%), the porosity of the composite scaffolds showed no significant variation compared with pure PLCL scaffolds (figure 5). The water contact angle of the PLCL film was 87.3 ± 2.8
• , which was not significantly different from the contact angle of the PHBV film (88.4 ± 5.1
• ) (figure S1 available at http://stacks.iop.org/BMM/8/025005/mmedia). . Compressive Young's modulus of PLCL scaffold, 20% PHBV/PLCL, 40% PHBV/PLCL and 50% PHBV/PLCL composite scaffolds, a statistical difference between all groups except for 40% PHBV/PLCL scaffolds and 50% PHBV/PLCL scaffolds (n = 6, * P < 0.05 compared with PLCL scaffold).
Compressive modulus of the scaffolds
Compressive strength of composite scaffolds increased substantially from 37 ± 5 kPa (PLCL scaffolds) to 77 ± 17 kPa (20% PHBV/PLCL) and 113 ± 15 kPa (40% PHBV/PLCL) to 123 ± 29 kPa (50% PHBV/PLCL) (figure 6) with the integration of PHBV microspheres. There was statistical difference between all groups except for 40% PHBV/PLCL scaffolds and 50% PHBV/PLCL scaffolds. A small amount of PHBV microspheres became detached from the PLCL matrix under the pre-loading stress, while the composite PHBV/PLCL scaffolds kept intact.
Morphology and distribution of chondrocytes in the scaffolds
The number of adhered cells on each group of composite scaffolds increased gradually with increasing culture time (P < 0.05). However, there was no significant variation between groups at 6 h, 2 weeks and 4 weeks (figure 7). Live-dead staining indicated that more than 95% of cells were distributed homogeneously and viable in all the scaffolds with fewer than 5% of cells dead at 6 h and 2 weeks (figure S4 available at http://stacks.iop.org/BMM/8/025005/mmedia). The chondrocytes appeared round in shape at 6 h in all the scaffolds, while spreading of chondrocytes was observed Figure 7 . DNA assay applied to investigate chondrocytes attachment at 6 h and proliferation at 2 and 4 weeks after cell seeding onto PLCL scaffold, 20% PHBV/PLCL and 40% PHBV/PLCL composite scaffolds. There is no significant difference among different scaffolds types, but the number of adhered cells increased gradually with increasing culture time. All the numbers of chondrocytes are shown as means ± SD 32 (n = 4).
at 2 weeks. However, there was no difference between the morphology of chondrocytes grown in the pure PLCL scaffolds and PHBV microspheres/PLCL composite scaffolds (figure 8).
In vitro cartilage formation of constructs
Though the GAG production increased significantly with time in all the scaffolds (P < 0.05), there was no significant difference among different scaffolds at both 2 and 4 weeks ( figure 9 ). Gene expression of aggrecan in all scaffolds increased with time, but no significant difference between different groups was observed, which was inconsistent with results of GAG quantification. Total type II collagen expression increased with culture time in all scaffolds (P < 0.05), while chondrocytes expressed no difference in type II collagen after 2 weeks and 4 weeks of culturing among different scaffolds (P > 0.05) (figure 10).
Histology of in vivo implantation
All mice were kept healthy without infection until killed, and all 24 implants were available for histology. H&E staining showed that the cells distributed evenly in all scaffolds (figures 11A, D and G). More cells and ECM were seen in all scaffolds at 8 weeks ( figure 12 A, D and G) . The structure of the scaffolds was maintained up to 8 weeks, with the microspheres embedded within the secreted ECM.
Uneven and similar Alcian Blue and type II collagen staining was seen in all groups at 4 weeks (figures 11B, E and H). The staining became denser and more homogeneous for all groups at 8 weeks when compared to the 4 week time point ( figure 12B, E and H) . The staining was stronger around the PHBV microspheres (within 5 μm) than the peripheral area (more than 5 μm) at 4 weeks (P < 0.05, figure S5 available at http://stacks.iop.org/BMM/8/025005/mmedia). However, this localized concentration became inconspicuous when the staining became stronger and homogeneous at 8 weeks (P > 0.05) (figure S6 available at stacks.iop.org/BMM).
Discussion
Mechanical properties of scaffolds such as compressive Young's modulus and elasticity are critical for cartilage regeneration [26] . Though elastic synthetic polymers have highly elastic properties, their compressive moduli are still much lower than native cartilage [11, 20] . There are three ways to enhance the strength of scaffolds: choosing materials which are of great strength, improving strength with chemical crosslinking and incorporating stiffer materials within the elastic scaffolds. Compared with choosing stiffer materials or increasing cross-links, incorporating stiffer materials, such as microspheres, has some advantages over the other strategies including maintaining porosity and increasing roughness of the surfaces. Another strategy to improve compressive Young's modulus is to decrease the porosity of the composite scaffolds. However, this strategy is not optimal since high porosity scaffolds offer advantages for tissue engineering.
PHBV-enhanced PLCL composite scaffolds could have an advantage in transferring external mechanical stimuli, both dynamic and static, to individual cells. It has been reported that proper cyclic mechanical stimuli could promote functionality of chondrocytes within scaffolds by selecting scaffolds with proper mechanical properties [20] . Composite scaffolds could meet these requirements through combining properties of different materials. Though PLCL scaffolds had relatively good recovery ratios and similar viscoelastic properties to native cartilage, their compressive modulus was one magnitude less than native cartilage [3] . Integration of PHBV microspheres with a relatively high compressive Young's modulus effectively enhanced compressive Young's modulus of the composite scaffolds [15] . The limitation to further enhance Young's modulus lies in the PHBV microspheres just mixing into the scaffolds and only supplying with physical support. When the percentage of PHBV microspheres increased to 40%, the microspheres were almost completely distributed throughout the matrix of the scaffolds. Once the PHBV microsphere proportion increased beyond 40%, there was no increase in compressive Young's modulus of the scaffolds. As the purpose of adding PHBV microspheres was to enhance the compressive Young's modulus of the scaffolds, the 50% PHBV/PLCL was omitted from the study since it did not increase Young's modulus further. Most PHBV Figure 9 . Quantitative analysis of GAG levels associated with the cell-scaffolds constructs engineered in vitro at 2 and 4 weeks. Data shown are means ± SD (n = 3, * P < 0.05 means the same scaffolds compared with different time point).
microsphere diameters used in this study were below 50 μm, and the median particle diameter of the microspheres was 37.2 μm. The particle-leaching method has been broadly employed to fabricate porous scaffolds, in which porosity, pore size distribution and inter-connectivity can be precisely regulated by tailoring the fabrication parameters such as the size of sodium chloride particles and amount of porogen. In our study, sodium chloride particles with diameters (200-300 μm) were employed to create pores in the PLCL scaffold matrix. Therefore, the addition of relatively small PHBV microspheres (37.2 μm) had little effect on pore size of the PLCL scaffolds. Without any chemical crosslinking, the PHBV microspheres were only incorporated into the PLCL matrix and thus no effect on scaffold degradation was observed (figure S7 available at http://stacks.iop.org/BMM/8/025005/mmedia). It took more than 1 year for PLCL scaffolds to degrade completely in vitro, while 81.3% mass of the PLCL scaffolds remained for more than 15 weeks in vivo [5] , and it took more than 1 year for PHBV scaffolds to degrade completely in vitro [27] . Our in vitro degradation experiments of PLCL and composite 40% PHBV/PLCL scaffolds also confirmed this finding, and only 10% of total mass of PLCL and 40% PHBV/PLCL scaffolds had been degraded after 2 months (figure S7 available at http://stacks.iop.org/BMM/8/025005/mmedia). Although the degradation times of the two different polymers varied slightly, in vivo cartilage tissue formation was found to occur by 3 months, well before scaffold degradation. During the preloading stress, a small amount of PHBV microspheres became detached from the PLCL matrix which probably did not impair the structure or the ultimate Young's modulus of composite PHBV/PLCL scaffolds, as the detached PHBV microspheres were those which loosely integrated with the PLCL matrix. Therefore, this new system could provide an intact structure for cartilage tissue regeneration.
Micro-scale surface topography has a great influence on cell attachment and proliferation [28] [29] [30] . Previous studies demonstrated that topography affects different cell types in varying ways and that different cell types prefer specific surface topographies. Mesenchymal stem cells have been shown to maintain their phenotype and high proliferation rate on island-patterned surfaces with 100 μm compared to 60 μm island-patterned surface and flat topography [31] . Cell adhesion and proliferation analysis showed that PHBV microspheres integrated into scaffolds did not significantly improve chondrocyte adhesion and proliferation, which may indicate that changing surface topography using this size of microspheres has little effect on chondrocyte adhesion and proliferation [32] . In order to distinguish the effects of the two materials, PHBV and PLCL, on the chondrocytes, the water contact angles, cell activit, attachment and proliferation on the PHBV and PLCL films were evaluated separately. All the results suggested that there were no significant differences in cell behavior on the PHBV and PLCL films (P > 0.05) (see supporting information, figures S1, S2 and S3, available at http://stacks.iop.org/BMM/8/025005/mmedia). In theory, the maximum area of human cell spreading is approximately 4000 μm 2 [33] . The area of islands formed by PHBV microspheres was about 2500 μm 2 , indicating that one PHBV microsphere could only attach one cell, but if the distance between PHBV microspheres was less than 20 μm, cells would be able to spread across multiple islands. With an increasing proportion of PHBV microspheres, the surface topography of composite scaffolds changed greatly. Once the amount of PHBV microspheres reached 40%, a large number of PHBV microspheres emerged on the surface of the PLCL matrix and joined closely with each other. When chondrocytes were loaded onto the composite scaffolds, they tended to attach onto the PHBV microspheres at the surface of composite scaffolds, which may induce more cartilage extracellular matrix formation around the PHBV microspheres at 4 weeks. Higher ECM deposition was localized around the PHBV microspheres in the composite constructs suggesting that chondrocytes adhering to the PHBV microspheres might have higher functionality. However, there was no significant variation on overall GAG and type II collagen content or gene expression among different scaffolds at 4 weeks. A previous study also demonstrated that although the incorporation of PHBV microspheres into the PLGA matrix significantly altered the roughness of the matrix and increased the compressive modulus of the composite scaffolds, the cells were opt to adhere onto or among the PHBV microspheres in the matrix [18] . Although there is not an advantageous cellular response to PHBV microsphere incorporation into PLCL scaffolds, apart from acquiring a higher compressive modulus scaffold, this new PHBV microsphere/PLCL system can also be potentially used to deliver bioactive factors or for controlled release of drugs while also functioning as a scaffold for cartilage regeneration. Differentiation of chondrocytes and secretion of ECM could further be regulated by immobilization of bioactive molecules onto PHBV microspheres in newly fabricated scaffolds in vitro.
Conclusions
Current PHBV microsphere/PLCL composite scaffolds have a relatively higher compressive strength than traditional PLCL scaffolds, good pore interconnectivity. The in vitro and in vivo evaluation of chondrocytes in the composite scaffolds demonstrated that the new systems were biocompatible and could serve as scaffolding structures for cartilaginous tissue formation. Future modifications to the scaffolds with bioactive molecules incorporated with the PHBV microspheres could also potentially serve as a new system in delivery of bioactive factors or drugs for functional cartilage tissue engineering.
